HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Olah, M. E. Articles by Caldwell, C. C. Search for Related Content PubMed PubMed Citation Articles by Olah, M. E. Articles by Caldwell, C. C.

Adenosine Receptors and Mammalian Toll-Like Receptors: Synergism in Macrophages

¹ Department of Pharmacology and Cell Biophysics,
² Department of Surgery, College of Medicine, University of Cincinnati, Cincinnati, OH 45267

SUMMARY

Adenosine is known to participate in tissue protection subsequent to ischemic events. New evidence points to a role for adenosine in promoting neovascularization through a mechanism that requires interaction with the Toll-like receptor (TLR) signaling pathway. In macrophages, the adenosine receptor subtype 2A (A_2AR) synergizes with some but not all of the Toll-like receptors, leading to increased expression of vascular endothelial growth factor (VEGF). Simultaneously, the expression of tumor necrosis factor– (TNF) is decreased; this phenomenon depends on the presence of AR agonists; however, the activation of transcription factor nuclear factor–B (NF–B) is not attenuated in the presence of A_2AR agonists. It appears that the addition of adenosine or other A_2AR agonists can mediate the "angiogenic switch," in macrophages, from TNF protein expression to expression of components necessary for angiogenesis. Although these observations might have important implications for wound healing, it will be important to discern whether this interaction between ARs and TLRs is necessary for angiogenesis associated with tumor growth.

This article has been cited by other articles:

				A. Haschemi, O. Wagner, R. Marculescu, B. Wegiel, S. C. Robson, N. Gagliani, D. Gallo, J.-F. Chen, F. H. Bach, and L. E. Otterbein Cross-Regulation of Carbon Monoxide and the Adenosine A2a Receptor in Macrophages J. Immunol., May 1, 2007; 178(9): 5921 - 5929. [Abstract] [Full Text] [PDF]

				J. Linden Adenosine metabolism and cancer. Focus on "Adenosine downregulates DPPIV on HT-29 colon cancer cells by stimulating protein tyrosine phosphatases and reducing ERK1/2 activity via a novel pathway" Am J Physiol Cell Physiol, September 1, 2006; 291(3): C405 - C406. [Full Text] [PDF]

				A. Desai, C. Victor-Vega, S. Gadangi, M. C. Montesinos, C. C. Chu, and B. N. Cronstein Adenosine A2A Receptor Stimulation Increases Angiogenesis by Down-Regulating Production of the Antiangiogenic Matrix Protein Thrombospondin 1 Mol. Pharmacol., May 1, 2005; 67(5): 1406 - 1413. [Abstract] [Full Text] [PDF]